Autophagy-Targeting Chimera (AUTOTAC) is a novel bifunctional molecule that simultaneously binds to pathological protein aggregates and recruits autophagy machinery, enabling selective degradation of misfolded proteins implicated in neurodegenerative diseases [1].
Pathway / Mechanism Diagram
graph TD
A["Nutrient Deprivation / Stress"] --> B["AMPK Activation"]
B --> C["ULK1 Complex Activation"]
A --> D["mTORC1 Inhibition"]
D --> C
C --> E["Phagophore Nucleation (VPS34/Beclin-1)"]
E --> F["LC3 Lipidation (LC3-II)"]
F --> G["Autophagosome Formation"]
G --> H["Cargo Recognition (p62/SQSTM1)"]
H --> I["Autophagosome-Lysosome Fusion"]
I --> J["Cargo Degradation"]
J --> K["Amino Acid Recycling"]
K --> L["Cell Survival"]
M["Autophagy Impairment in Aging"] --> N["Aggregate Accumulation"]
N --> O["Tau, Abeta, alpha-Synuclein Buildup"]
O --> P["Neurodegeneration"]
style L fill:#1b5e20,color:#e0e0e0
style P fill:#ef5350,color:#e0e0e0
style G fill:#006494,color:#e0e0e0
Mechanistic Rationale
Dual-Targeting Mechanism
AUTOTAC molecules consist of two functional domains:
Aggregate-binding domain: Small molecule or peptide that recognizes and binds to specific protein aggregates (Aβ, tau, α-synuclein, TDP-43, SOD1)
Autophagy-recruiting domain: Phosphoinositide binding motif or LC3-interacting region (LIR) that recruits autophagosomes [2][6]
...
Overview
Autophagy-Targeting Chimera (AUTOTAC) is a novel bifunctional molecule that simultaneously binds to pathological protein aggregates and recruits autophagy machinery, enabling selective degradation of misfolded proteins implicated in neurodegenerative diseases [1].
Pathway / Mechanism Diagram
Mermaid diagram (expand to render)
Mechanistic Rationale
Dual-Targeting Mechanism
AUTOTAC molecules consist of two functional domains:
Aggregate-binding domain: Small molecule or peptide that recognizes and binds to specific protein aggregates (Aβ, tau, α-synuclein, TDP-43, SOD1)
Autophagy-recruiting domain: Phosphoinositide binding motif or LC3-interacting region (LIR) that recruits autophagosomes [2][6]
Degradation Pathway
[ ] AUTOTAC binds pathological aggregate
[ ] LIR domain recruits LC3 on autophagosome membrane
[ ] Formed autophagosome engulfs the aggregate-AUTOTAC complex
[ ] Lysosomal fusion leads to aggregate degradation
[Autophagy-lysosome pathway convergence across neurodegenerative diseases](/analysis/SDA-2026-04-01-gap-011) 🔄
Pathway Diagram
The following diagram shows the key molecular relationships involving Autophagy-Targeting Chimera (AUTOTAC) Therapy discovered through SciDEX knowledge graph analysis: